Search | SciELO

Need help?

Add field +

Search history

No documents were found for your search

Results: 16

au:"Marques, Heloisa Helena de Sousa"

Filters

Collection + Options

All
Brazil

12
Public Health

4

Journal + Options

All
Cadernos de Saúde Pública

8
Clinics

3
Radiologia Brasileira

1
Revista Brasileira de Ginecologia e Obstetrícia

1
Revista Paulista de Pediatria

1
Revista da Sociedade Brasileira de Medicina Tropical

1
Revista do Instituto de Medicina Tropical de São Paulo

1

Language

All
Portuguese

4

Publication Year + Options

All
2007

4
2006

3
2011

2
2015

2
2022

2
2014

1
2020

1
2021

1

SciELO Thematic Areas + Options

All
Health Sciences

16
Biological Sciences

1

WoS Subject Categories + Options

All
Health

8
Medicine

6
Environmental

4
Occupational

4
Policy

4
Public

4
Services

4
General

3
Internal

3
Tropical

2
Gynecology

1
Imaging

1
Medical

1
Nuclear

1
Obstetrics

1

Show all...

WoS Citation Index + Options

All
Science Citation Index Expanded

13
Social Sciences Citation Index

4

Citables and non citables

All
Citable

16

Type of Literature + Options

All
Article

15
Brief report

1

Order by

Page of 2 Next

Select this page

Print | Send to email | Export |

Facebook
Twitter
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Other networks

0 Selected itens

List all
Erase all

Radiological patterns of pulmonary fungal infection in pediatric hematology and oncology patients
Facebook Twitter

Other social networks
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Other networks

Metrics
- SciELO Analytics
- Dimensions
- PlumX
- Altmetric

Bain, Vera

; Barrientos, Anna Carlota Mott Galvão de Arruda

; Suzuki, Lisa

; Oliveira, Luiz Antonio Nunes de

; Litvinov, Nadia

; Peron, Karina Rodrigues

; Fernandes, Juliana Folloni

; Marques, Heloisa Helena de Sousa

Radiologia Brasileira

Journal Metrics
- Sobre o periódico
- SciELO Analytics

mar 2022, Volume 55 N. 2 Pages 78 - 83

Abstract: Pt En | Text: Pt En | PDF: Pt | PDF: En

Resumo Objetivo: O objetivo deste estudo é descrever os achados radiológicos de infecções fúngicas invasivas em crianças com doenças onco-hematológicas em um único centro, de acordo com a classificação antiga e a atual de imagens típicas e atípicas. Materiais e Métodos: Foram revisados os prontuários de todos os pacientes com infecção fúngica invasiva que foram internados em um hospital pediátrico de oncologia e hematologia de 2008 a 2014. Foram coletados dados clínicos e demográficos. As tomografias de tórax dos pacientes foram laudadas por dois radiologistas independentes. Resultados: Foram identificados 40 pacientes com infecção fúngica invasiva que realizaram tomografias de tórax. Vinte e sete pacientes apresentaram nódulos com sinal do halo (67,5%), sete tiveram cavitações (17,5%), dois tiveram nódulos sem halo (5,0%) e sete apresentaram consolidações (17,5%). Os pacientes que apresentavam achados de nódulos com sinal do halo e cavitações eram mais velhos (123 versus 77 meses; p = 0,03) e tinham menos sinais de doença grave (34% versus 73%; p = 0,04) do que os outros pacientes. Dez crianças apresentaram infecção confirmada (Aspergillus sp., n = 4; Candida sp., n = 5; Fusarium sp., n = 1). Conclusão: O diagnóstico de infecção fúngica invasiva deve ser considerado em crianças com fatores de risco e tomografias de tórax alteradas, mesmo que os achados das imagens sejam inespecíficos.

Abstract Objective: To describe the radiological findings in pediatric patients with hematological or oncological diseases who also have an invasive fungal infection (IFI). Materials and Methods: This was a retrospective study of all patients with IFI admitted to a pediatric hematology and oncology hospital in Brazil between 2008 and 2014. Clinical and demographic data were collected. Chest computed tomography (CT) scans of the patients were reviewed by two independent radiologists. Results: We evaluated the chest CT scans of 40 pediatric patients diagnosed with an IFI. Twenty-seven patients (67.5%) had nodules with the halo sign, seven (17.5%) had cavities, two (5.0%) had nodules without the halo sign, and seven (17.5%) had consolidation. The patients with the halo sign and cavities were older (123 vs. 77 months of age; p = 0.03) and had less severe disease (34% vs. 73%; p = 0.04). Ten patients had a proven IFI: with Aspergillus sp. (n = 4); with Candida sp. (n = 5); or with Fusarium sp. (n = 1). Conclusion: A diagnosis of IFI should be considered in children and adolescents with risk factors and abnormal CT scans, even if the imaging findings are nonspecific.

https://doi.org/10.1590/0100-3984.2021.0055

SARS-CoV-2 and rhinovirus infections: are there differences in clinical presentation, laboratory abnormalities, and outcomes in the pediatric population?
Facebook Twitter

Other social networks
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Other networks

Metrics
- SciELO Analytics
- Dimensions
- PlumX
- Altmetric

Pereira, Maria Fernanda Bádue

; Suguita, Priscila

; Litvinov, Nadia

; Farhat, Sylvia Costa Lima

; Paula, Camila Sanson Yoshino de

; Lázari, Carolina dos Santos

; Bedê, Pedro Vale

; Framil, Juliana Valeria de Souza

; Bueno, Catarina

; Branas, Priscila Cristina Abduch Adas

; Guimarães, Irina Monteiro da Costa

; Leite, Marcia Marques

; Navega, Ana Carolina Barsaglini

; Nanbu, Danilo Yamamoto

; Schvartsman, Claudio

; Pinho, João Renato Rebello

; Silva, Clovis Artur Almeida

; Marques, Heloisa Helena de Sousa

; Eisencraft, Adriana Pasmanik

; Rossi Jr, Alfio

; Delgado, Artur Figueiredo

; Leal, Gabriela Nunes

; Gibelli, Maria Augusta Cicaroni

; Palmeira, Patricia

; Sakita, Neusa Keico

; Santos, Emilly Henrique dos

; Rocha, Mussya Cisotto

; Kanunfre, Kelly Aparecida

; Okay, Thelma Suely

; Carneiro-Sampaio, Magda

; Carvalho, Werther Brunow de

Revista do Instituto de Medicina Tropical de São Paulo

Journal Metrics
- Sobre o periódico
- SciELO Analytics

2022, Volume 64 elocation e34

Abstract: En | Text: En | PDF: En

ABSTRACT This study aims to assess COVID-19 and other respiratory viruses in pediatric patients. Between April 17 and September 30, 2020, we collected 1,566 respiratory samples from 1,044 symptomatic patients who were younger than 18 years old to assess SARS-CoV-2 infection. Of these, 919 were analyzed for other respiratory pathogens (ORP). Patients with laboratory-confirmed COVID-19 or ORP were included. We evaluated 76 pediatric COVID-19 infections and 157 other respiratory virus infections. Rhinovirus occurred in 132/157 (84%). COVID-19 patients who were significantly older, had more fevers, headaches and pneumonia than those with ORP. The median white blood cell count was lower in patients with SARS-CoV-2 than in those with ORP (6,470 versus 8,170; p=0.02). COVID-19 patients had significantly worse symptoms than those with ORP.

https://doi.org/10.1590/s1678-9946202264034

Differences in children and adolescents with SARS-CoV-2 infection: a cohort study in a Brazilian tertiary referral hospital
Facebook Twitter

Other social networks
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Other networks

Metrics
- SciELO Analytics
- Dimensions
- PlumX
- Altmetric

Marques, Heloisa Helena de Sousa

; Pereira, Maria Fernanda Badue

; Santos, Angélica Carreira dos

; Fink, Thais Toledo

; Paula, Camila Sanson Yoshino de

; Litvinov, Nadia

; Schvartsman, Claudio

; Delgado, Artur Figueiredo

; Gibelli, Maria Augusta Bento Cicaroni

; Carvalho, Werther Brunow de

; Odone Filho, Vicente

; Tannuri, Uenis

; Carneiro-Sampaio, Magda

; Grisi, Sandra

; Duarte, Alberto José da Silva

; Antonangelo, Leila

; Francisco, Rossana Pucineli Vieira

; Okay, Thelma Suely

; Batisttella, Linamara Rizzo

; Carvalho, Carlos Roberto Ribeiro de

; Brentani, Alexandra Valéria Maria

; Silva, Clovis Artur

; Eisencraft, Adriana Pasmanik

; Rossi Junior, Alfio

; Fante, Alice Lima

; Cora, Aline Pivetta

; Reis, Amelia Gorete A. de Costa

; Ferrer, Ana Paula Scoleze

; Andrade, Anarella Penha Meirelles de

; Watanabe, Andreia

; Gonçalves, Angelina Maria Freire

; Waetge, Aurora Rosaria Pagliara

; Silva, Camila Altenfelder

; Ceneviva, Carina

; Lazari, Carolina dos Santos

; Abellan, Deipara Monteiro

; Santos, Emilly Henrique dos

; Sabino, Ester Cerdeira

; Bianchini, Fabíola Roberta Marim

; Alcantara, Flávio Ferraz de Paes

; Ramos, Gabriel Frizzo

; Leal, Gabriela Nunes

; Rodriguez, Isadora Souza

; Pinho, João Renato Rebello

; Carneiro, Jorge David Avaizoglou

; Paz, Jose Albino

; Ferreira, Juliana Carvalho

; Ferranti, Juliana Ferreira

; Ferreira, Juliana de Oliveira Achili

; Framil, Juliana Valéria de Souza

; Silva, Katia Regina da

; Kanunfre, Kelly Aparecida

; Bastos, Karina Lucio de Medeiros

; Galleti, Karine Vusberg

; Cristofani, Lilian Maria

; Suzuki, Lisa

; Campos, Lucia Maria Arruda

; Perondi, Maria Beatriz de Moliterno

; Diniz, Maria de Fatima Rodrigues

; Fonseca, Maria Fernanda Mota

; Cordon, Mariana Nutti de Almeida

; Pissolato, Mariana

; Peres, Marina Silva

; Garanito, Marlene Pereira

; Imamura, Marta

; Dorna, Mayra de Barros

; Luglio, Michele

; Rocha, Mussya Cisotto

; Aikawa, Nadia Emi

; Degaspare, Natalia Viu

; Sakita, Neusa Keico

; Udsen, Nicole Lee

; Scudeller, Paula Gobi

; Gaiolla, Paula Vieira de Vincenzi

; Severini, Rafael da Silva Giannasi

; Rodrigues, Regina Maria

; Toma, Ricardo Katsuya

; Paula, Ricardo Iunis Citrangulo de

; Palmeira, Patricia

; Forsait, Silvana

; Farhat, Sylvia Costa Lima

; Sakano, Tânia Miyuki Shimoda

; Koch, Vera Hermina Kalika

; Cobello Junior, Vilson

Clinics

Journal Metrics
- Sobre o periódico
- SciELO Analytics

2021, Volume 76 elocation e3488

Abstract: En | Text: En | PDF: En

OBJECTIVES: To compare demographic/clinical/laboratory/treatments and outcomes among children and adolescents with laboratory-confirmed coronavirus disease 2019 (COVID-19). METHODS: This was a cross-sectional study that included patients diagnosed with pediatric COVID-19 (aged <18 years) between April 11, 2020 and April 22, 2021. During this period, 102/5,951 (1.7%) of all admissions occurred in neonates, children, and adolescents. Furthermore, 3,962 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection samples were processed in patients aged <18 years, and laboratory-confirmed COVID-19 occurred in 155 (4%) inpatients and outpatients. Six/155 pediatric patients were excluded from the study. Therefore, the final group included 149 children and adolescents (n=97 inpatients and 52 outpatients) with positive SARS-CoV-2 results. RESULTS: The frequencies of sore throat, anosmia, dysgeusia, headache, myalgia, nausea, lymphopenia, pre-existing chronic conditions, immunosuppressive conditions, and autoimmune diseases were significantly reduced in children and adolescents (p<0.05). Likewise, the frequencies of enoxaparin use (p=0.037), current immunosuppressant use (p=0.008), vasoactive agents (p=0.045), arterial hypotension (p<0.001), and shock (p=0.024) were significantly lower in children than in adolescents. Logistic regression analysis showed that adolescents with laboratory-confirmed COVID-19 had increased odds ratios (ORs) for sore throat (OR 13.054; 95% confidence interval [CI] 2.750-61.977; p=0.001), nausea (OR 8.875; 95% CI 1.660-47.446; p=0.011), and lymphopenia (OR 3.575; 95% CI 1.355-9.430; p=0.010), but also had less hospitalizations (OR 0.355; 95% CI 0.138-0.916; p=0.032). The additional logistic regression analysis on patients with preexisting chronic conditions (n=108) showed that death as an outcome was significantly associated with pediatric severe acute respiratory syndrome (SARS) (OR 22.300; 95% CI 2.341-212.421; p=0.007) and multisystem inflammatory syndrome in children (MIS-C) (OR 11.261; 95% CI 1.189-106. 581; p=0.035). CONCLUSIONS: Half of the laboratory-confirmed COVID-19 cases occurred in adolescents. Individuals belonging to this age group had an acute systemic involvement of SARS-CoV-2 infection. Pediatric SARS and MIS-C were the most important factors associated with the mortality rate in pediatric chronic conditions with COVID-19.

https://doi.org/10.6061/clinics/2021/e3488

Severe clinical spectrum with high mortality in pediatric patients with COVID-19 and multisystem inflammatory syndrome
Facebook Twitter

Other social networks
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Other networks

Metrics
- SciELO Analytics
- Dimensions
- PlumX
- Altmetric

Pereira, Maria Fernanda Badue

; Litvinov, Nadia

; Farhat, Sylvia Costa Lima

; Eisencraft, Adriana Pasmanik

; Gibelli, Maria Augusta Bento Cicaroni

; Carvalho, Werther Brunow de

; Fernandes, Vinicius Rodrigues

; Fink, Thais de Toledo

; Framil, Juliana Valéria de Souza

; Galleti, Karine Vusberg

; Fante, Alice Lima

; Fonseca, Maria Fernanda Mota

; Watanabe, Andreia

; Paula, Camila Sanson Yoshino de

; Palandri, Giovanna Gavros

; Leal, Gabriela Nunes

; Diniz, Maria de Fatima Rodrigues

; Pinho, João Renato Rebello

; Silva, Clovis Artur

; Marques, Heloisa Helena de Sousa

; Rossi Junior, Alfio

; Delgado, Artur Figueiredo

; Andrade, Anarella Penha Meirelles de

; Schvartsman, Claudio

; Sabino, Ester Cerdeira

; Rocha, Mussya Cisotto

; Kanunfre, Kelly Aparecida

; Okay, Thelma Suely

; Carneiro-Sampaio, Magda Maria Sales

; Jorge, Patricia Palmeira Daenekas

Clinics

Journal Metrics
- Sobre o periódico
- SciELO Analytics

2020, Volume 75 elocation e2209

Abstract: En | Text: En | PDF: En

OBJECTIVES: To assess the outcomes of pediatric patients with laboratory-confirmed coronavirus disease (COVID-19) with or without multisystem inflammatory syndrome in children (MIS-C). METHODS: This cross-sectional study included 471 samples collected from 371 patients (age<18 years) suspected of having severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The study group comprised 66/371 (18%) laboratory-confirmed pediatric COVID-19 patients: 61 (92.5%) patients tested positive on real-time reverse transcription-polymerase chain reaction tests for SARS-CoV-2, and 5 (7.5%) patients tested positive on serological tests. MIS-C was diagnosed according to the criteria of the Center for Disease Control. RESULTS: MIS-C was diagnosed in 6/66 (9%) patients. The frequencies of diarrhea, vomiting, and/or abdominal pain (67% vs. 22%, p=0.034); pediatric SARS (67% vs. 13%, p=0.008); hypoxemia (83% vs. 23%, p=0.006); and arterial hypotension (50% vs. 3%, p=0.004) were significantly higher in patients with MIS-C than in those without MIS-C. The frequencies of C-reactive protein levels >50 mg/L (83% vs. 25%, p=0.008) and D-dimer levels >1000 ng/mL (100% vs. 40%, p=0.007) and the median D-dimer, troponin T, and ferritin levels (p<0.05) were significantly higher in patients with MIS-C. The frequencies of pediatric intensive care unit admission (100% vs. 60%, p=0.003), mechanical ventilation (83% vs. 7%, p<0.001), vasoactive agent use (83% vs. 3%, p<0.001), shock (83% vs. 5%, p<0.001), cardiac abnormalities (100% vs. 2%, p<0.001), and death (67% vs. 3%, p<0.001) were also significantly higher in patients with MIS-C. Similarly, the frequencies of oxygen therapy (100% vs. 33%, p=0.003), intravenous immunoglobulin therapy (67% vs. 2%, p<0.001), aspirin therapy (50% vs. 0%, p<0.001), and current acute renal replacement therapy (50% vs. 2%, p=0.002) were also significantly higher in patients with MIS-C. Logistic regression analysis showed that the presence of MIS-C was significantly associated with gastrointestinal manifestations [odds ratio (OR)=10.98; 95%CI (95% confidence interval)=1.20-100.86; p=0.034] and hypoxemia [OR=16.85; 95%CI=1.34-211.80; p=0.029]. Further univariate analysis showed a positive association between MIS-C and death [OR=58.00; 95%CI=6.39-526.79; p<0.0001]. CONCLUSIONS: Pediatric patients with laboratory-confirmed COVID-19 with MIS-C had a severe clinical spectrum with a high mortality rate. Our study emphasizes the importance of investigating MIS-C in pediatric patients with COVID-19 presenting with gastrointestinal involvement and hypoxemia.

https://doi.org/10.6061/clinics/2020/e2209 2260 downloads

Alta prevalência de sedentarismo em adolescentes que vivem com HIV/Aids
Facebook Twitter

Other social networks
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Other networks

Metrics
- SciELO Analytics
- Dimensions
- PlumX
- Altmetric

Tanaka, Luana Fiengo

; Latorre, Maria do Rosário Dias de Oliveira

; Silva, Aline Medeiros

; Konstantyner, Thais Claudia Roma de Oliveira

; Peres, Stela Verzinhasse

; Marques, Heloisa Helena de Sousa

Revista Paulista de Pediatria

Journal Metrics
- Sobre o periódico
- SciELO Analytics

sep 2015, Volume 33 N. 3 Pages 326 - 331

Abstract: Pt En | Text: Pt En | PDF: Pt | PDF: En

ResumoObjetivo:Verificar a prevalência de sedentarismo entre adolescentes com HIV/Aids e seus fatores associados.Métodos:Foram entrevistados 91 adolescentes de 10 a 19 anos, com HIV/Aids, em acompanhamento em uma unidade de infectologia universitária. Foram coletados dados antropométricos (peso, altura e circunferência da cintura) em duplicata, informações clínicas foram obtidas nos prontuários médicos e a prática de atividade física habitual foi medida por meio do questionário proposto por Florindo et al. O ponto de corte para sedentarismo foi de 300 minutos/semana.Resultados:As prevalências de altura inadequada para idade, desnutrição e sobrepeso/obesidade foram de 15,4%, 9,9% e 12,1%, respectivamente. As atividades físicas mais citadas foram: futebol (44,4%), voleibol (14,4%) e andar de bicicleta (7,8%). Os tempos medianos dispendidos com a prática de atividade física e caminhando/andando de bicicleta até a escola foram de 141 minutos e 39 minutos, respectivamente. A maioria dos adolescentes (71,4%) era sedentária, proporção maior entre as meninas (p=0,046).Conclusões:Foi observada alta prevalência de sedentarismo entre adolescentes com HIV/Aids, prevalência essa semelhante àquela observada na população geral. Promover a prática de atividade física entre adolescentes - especialmente entre meninas - com HIV/Aids, assim como monitorá-la, deve fazer parte da rotina de acompanhamento desses pacientes.

AbstractObjective:To assess the prevalence of physical inactivity among adolescents with HIV/AIDS, as well as associated factors.Methods:Ninety-one adolescents (from 10 to 19 years old) with HIV/AIDS who are patients at a university follow-up service were interviewed. Anthropometric data (weight, height, and waist circumference) were measured twice; clinical information was obtained from medical records, and habitual physical activity was assessed by a questionnaire proposed by Florindo et al. The cutoff point for sedentariness was 300 minutes/week.Results:The prevalence of inadequate height for age, malnutrition, and overweight/obesity was 15.4%, 9.9% and 12.1%, respectively. The most common physical activities were soccer (44.4%), volleyball (14.4%) and cycling (7.8%). The median times spent with physical activity and walking/bicycling to school were 141 min and 39 min, respectively. Most adolescents (71.4%) were sedentary and this proportion was higher among girls (p=0.046).Conclusions:A high prevalence of physical inactivity among adolescents with HIV/AIDS was observed, similar to the general population. Promoting physical activity among adolescents, especially among girls with HIV/AIDS, as well as monitoring it should be part of the follow-up routine of these patients.

https://doi.org/10.1016/j.rpped.2014.12.003 3655 downloads

Cytomegalovirus infection in transplant recipients
Facebook Twitter

Other social networks
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Other networks

Metrics
- SciELO Analytics
- Dimensions
- PlumX
- Altmetric

Azevedo, Luiz Sergio

; Pierrotti, Lígia Camera

; Abdala, Edson

; Costa, Silvia Figueiredo

; Strabelli, Tânia Mara Varejão

; Campos, Silvia Vidal

; Ramos, Jéssica Fernandes

; Latif, Acram Zahredine Abdul

; Litvinov, Nadia

; Maluf, Natalya Zaidan

; Filho, Helio Hehl Caiaffa

; Pannuti, Claudio Sergio

; Lopes, Marta Heloisa

; Santos, Vera Aparecida dos

; Linardi, Camila da Cruz Gouveia

; Yasuda, Maria Aparecida Shikanai

; Marques, Heloisa Helena de Sousa

Clinics

Journal Metrics
- Sobre o periódico
- SciELO Analytics

jul 2015, Volume 70 N. 7 Pages 515 - 523

Abstract: En | Text: En | PDF: En

Cytomegalovirus infection is a frequent complication after transplantation. This infection occurs due to transmission from the transplanted organ, due to reactivation of latent infection, or after a primary infection in seronegative patients and can be defined as follows: latent infection, active infection, viral syndrome or invasive disease. This condition occurs mainly between 30 and 90 days after transplantation. In hematopoietic stem cell transplantation in particular, infection usually occurs within the first 30 days after transplantation and in the presence of graft-versus-host disease. The major risk factors are when the recipient is cytomegalovirus seronegative and the donor is seropositive as well as when lymphocyte-depleting antibodies are used. There are two methods for the diagnosis of cytomegalovirus infection: the pp65 antigenemia assay and polymerase chain reaction. Serology has no value for the diagnosis of active disease, whereas histology of the affected tissue and bronchoalveolar lavage analysis are useful in the diagnosis of invasive disease. Cytomegalovirus disease can be prevented by prophylaxis (the administration of antiviral drugs to all or to a subgroup of patients who are at higher risk of viral replication) or by preemptive therapy (the early diagnosis of viral replication before development of the disease and prescription of antiviral treatment to prevent the appearance of clinical disease). The drug used is intravenous or oral ganciclovir; oral valganciclovir; or, less frequently, valacyclovir. Prophylaxis should continue for 90 to 180 days. Treatment is always indicated in cytomegalovirus disease, and the gold-standard drug is intravenous ganciclovir. Treatment should be given for 2 to 3 weeks and should be continued for an additional 7 days after the first negative result for viremia.

https://doi.org/10.6061/clinics/2015(07)09 3565 downloads

Management of post-transplant Epstein-Barr virus-related lymphoproliferative disease in solid organ and hematopoietic stem cell recipients
Facebook Twitter

Other social networks
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Other networks

Metrics
- SciELO Analytics
- Dimensions
- PlumX
- Altmetric

Marques, Heloisa Helena de Sousa

; Shikanai-Yasuda, Maria Aparecida

; Azevedo, Luiz Sérgio Fonseca de

; Caiaffa-Filho, Hélio Helh

; Pierrotti, Lígia Camera

; Aquino, Maria Zilda de

; Lopes, Marta Heloisa

; Maluf, Natalya Zaidan

; Campos, Silvia Vidal

; Costa, Silvia Figueiredo

Revista da Sociedade Brasileira de Medicina Tropical

Journal Metrics
- Sobre o periódico
- SciELO Analytics

oct 2014, Volume 47 N. 5 Pages 543 - 546

Abstract: En | Text: En | PDF: En

Epstein-Barr virus (EBV)-related post-transplant lymphoproliferative disease (PTLD) is one of the most serious complications associated with solid organ and hematopoietic stem cell transplantation. PTLD is most frequently seen with primary EBV infection post-transplant, a common scenario for pediatric solid organ recipients. Risk factors for infection or reactivation of EBV following solid organ transplant are stronger immunosuppressive therapy regimens, and being seronegative for receptor. For hematopoietic stem cell transplantation, the risk factors relate to the type of transplant, human leukocyte antigen disparity, the use of stronger immunosuppressants, T-cell depletion, and severe graft-versus-host disease. Mortality is high, and most frequent in patients who develop PTLD in the first six months post-transplant. The primary goal of this article is to provide an overview of the clinical manifestations, diagnosis, accepted therapies, and management of EBV infection in transplant recipients, and to suggest that the adoption of monitoring protocols could contribute to a reduction in related complications.

https://doi.org/10.1590/0037-8682-0036-2014 4778 downloads

Improving survival in children with AIDS in Brazil: results of the second national study, 1999-2002
Facebook Twitter

Other social networks
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Other networks

Metrics
- SciELO Analytics

Matida, Luiza Harunari

; Ramos Jr., Alberto Novaes

; Heukelbach, Jorg

; Sañudo, Adriana

; Succi, Regina Célia de Menezes

; Marques, Heloisa Helena de Sousa

; Negra, Marinella Della

; Hearst, Norman

Cadernos de Saúde Pública

Journal Metrics
- Sobre o periódico
- SciELO Analytics

2011, Volume 27 Suppl. 1 Pages s93 - s103

Abstract: Pt En | Text: Pt En | PDF: Pt | PDF: En

Este estudo caracteriza a sobrevida em crianças com AIDS no Brasil entre 1999-2002, contextualizando com o primeiro estudo nacional (1983-1998). Trata-se de coorte histórica, com crianças expostas ao HIV por transmissão vertical e acompanhadas até 2007. A probabilidade de sobrevivência em 60 meses foi analisada segundo sexo, ano de nascimento e de óbito, classificação clínica, uso de terapia antirretroviral (TARV) e de profilaxia para doenças oportunistas. No total, 920 crianças foram incluídas. A probabilidade de sobrevivência foi ampliada 3,5 vezes nos dois períodos avaliados, passando de 25% antes de 1988 para 86,3% no período de 2001-2002. Uso de TARV, classificação clínica inicial e atual/final foram preditores que influíram significativamente (p < 0,001) para a ampliação da sobrevida. Os resultados deste estudo indicam o sucesso da política brasileira para a abordagem das crianças infectadas com HIV. A melhora do estado clínico contribuiu para melhora da qualidade de vida, mas sinaliza-se para a necessidade de incorporação de práticas pautadas na integralidade do cuidado.

The objective of this study is to characterize survival in children with AIDS diagnosed in Brazil between 1999-2002, compared with the first national study (1983-1998). This national retrospective cohort study examined a representative sample of Brazilian children exposed to HIV from mother-to-child transmission and followed through 2007. The survival probability after 60 months was analyzed by sex, year of birth and death, clinical classification, use of antiretroviral therapy (ART) and prophylaxis for opportunistic diseases. 920 children were included. The survival probability increased: comparing cases diagnosed before 1988 with those diagnosed from 2001-2002 it increased by 3.5-fold (from 25% to 86.3%). Use of ART, initial clinical classification, and final classification were significant (p < 0.001) predictors of survival. Issues regarding quality of records and care were identified. The results point to the success of the Brazilian policy of providing ART. The improvement of clinical status contributes to quality of life, while indicating challenges, particularly practices to improve long-term care.

1229 downloads Cited 7 times in SciELO

Improving survival in children with AIDS in Brazil: results of the second national study, 1999-2002
Facebook Twitter

Other social networks
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Other networks

Metrics
- SciELO Analytics

Matida, Luiza Harunari

; Ramos Jr., Alberto Novaes

; Heukelbach, Jorg

; Sañudo, Adriana

; Succi, Regina Célia de Menezes

; Marques, Heloisa Helena de Sousa

; Negra, Marinella Della

; Hearst, Norman

Cadernos de Saúde Pública

Journal Metrics
- Sobre o periódico
- SciELO Analytics

2011, Volume 27 Suppl. 1 Pages s93 - s103

Abstract: Pt En | Text: Pt En | PDF: Pt | PDF: En

2530 downloads Cited 7 times in SciELO

10.

AIDS by mother-to-child transmission: survival analysis of cases followed from 1983 to 2002 in different regions of Brazil
Facebook Twitter

Other social networks
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Other networks

Metrics
- SciELO Analytics

Matida, Luiza Harunari

; Ramos Jr., Alberto Novaes

; Moncau, José Eduardo Cajado

; Marcopito, Luiz Francisco

; Marques, Heloisa Helena de Sousa

; Succi, Regina Célia Menezes

; Della Negra, Marinella

; Hearst, Norman

Cadernos de Saúde Pública

Journal Metrics
- Sobre o periódico
- SciELO Analytics

2007, Volume 23 Suppl. 3 Pages S435 - S444

Abstract: Pt En | Text: Pt En | PDF: Pt | PDF: En

A terapia anti-retroviral contribui para a diminuição da morbidade e da mortalidade, com conseqüente aumento da sobrevida. No Brasil, há diferenças regionais relativas à dinâmica da epidemia do HIV e ao seu enfrentamento no grupo das gestantes e das crianças com HIV/AIDS. Este estudo verifica o tempo de sobrevida após o diagnóstico de AIDS em 914 crianças infectadas por transmissão vertical, entre os anos de 1983 e 1998, e acompanhadas até 2002, nas cinco regiões brasileiras. O tempo do nascimento ao diagnóstico de infecção pelo HIV, ao longo dos anos, apresenta uma diminuição, principalmente nos estados das regiões Sul e Sudeste. Houve melhora significativa da sobrevivência, mais de 75% dos casos ainda estavam vivendo quatro anos após o diagnóstico, no grupo de 1997 e 1998. Esta análise brasileira mostra ser possível para um país em desenvolvimento estabelecer um sistema efetivo de acesso gratuito e universal à terapia anti-retroviral, mesmo com dificuldades regionais para a organização de uma infra-estrutura ideal de saúde, tendo como resultado um aumento significativo da sobrevivência.

Antiretroviral therapy contributes to decreasing morbidity and mortality, and ultimately to increasing survival. In Brazil, there are regional differences in HIV epidemiology regarding pregnant women and children with HIV/AIDS. This study evaluates survival time after AIDS diagnosis in 914 children infected by mother-to-child transmission, reported between 1983 and 1998 and followed until 2002, in Brazil's five regions. Time between birth and HIV diagnosis decreased over the years, mainly in the South and Southeast Regions. There was a significant improvement in survival; more than 75% of cases were still living four years after diagnosis in the 1997-1998 group. This Brazilian study demonstrates that even with regional inequalities in health care infrastructure it is possible for a developing country to establish an effective system of universal and free access to antiretroviral therapy that produces a significant increase in survival for children with AIDS.

1258 downloads Cited 10 times in SciELO

11.

Costs of care provided in a university hospital for children exposed to or infected with the HIV/AIDS
Facebook Twitter

Other social networks
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Other networks

Metrics
- SciELO Analytics

Marques, Heloisa Helena de Sousa

; Couttolenc, Bernard François

; Latorre, Maria do Rosário Dias de Oliveira

; Aquino, Maria Zilda de

; Aveiro, Maria Ignez Garcia

; Pluciennik, Ana Maria Aratangy

Cadernos de Saúde Pública

Journal Metrics
- Sobre o periódico
- SciELO Analytics

2007, Volume 23 Suppl. 3 Pages S402 - S413

Abstract: Pt En | Text: Pt En | PDF: Pt | PDF: En

O objetivo deste estudo foi estimar e analisar os custos de tratamento da criança com HIV/AIDS em um hospital universitário de São Paulo, Brasil. Foram analisados 291 prontuários de crianças expostas ou infectadas acompanhadas no Instituto da Criança, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, em março de 2002. O custo foi estimado por categoria de paciente (exposta e infectada) e nível de gravidade (graves e leves/moderados), com base na quantidade de procedimentos e insumos utilizados no tratamento, e valorizado monetariamente por meio do sistema de apuração de custos existente no Instituto da Criança. O custo total estimado de tratamento da criança exposta ao HIV foi de R$ 956,41 e da criança infectada de R$ 8.092,71 por ano. O custo do tratamento ambulatorial foi de R$ 6.047,28, R$ 3.714,45 e R$ 948,63, respectivamente para os pacientes infectados graves, leves/moderados e para as crianças expostas, e o custo médio de internação foi de R$ 19.353,34, R$ 18.823,16 e R$ 871,03, respectivamente. O custo foi fortemente influenciado pelo consumo de medicamentos e comparável aos obtidos pelos demais estudos publicados, embora inferior ao estimado em estudos internacionais.

The objective of this study was to estimate and analyze the costs of treating children with HIV/AIDS at a university hospital in São Paulo, Brazil. The study collected and analyzed data from 291 medical records of children treated at the hospital as of March 2002. The costs of treatment were estimated for each category of patient (exposed and infected) and severity, based on the quantity of inputs and procedures used in treating each child, based on the cost accounting system used at the hospital. The total cost of treatment for children exposed to the HIV was R$ 956.41 and for those infected with HIV R$ 8,092.71 per year. The mean cost of ambulatory care was R$ 6,047.28 for children with severe conditions, R$ 3,714.45 for those with light/moderate conditions, and R$ 948.63 for the exposed. Hospitalized children had annual costs of R$ 19,353.34, R$ 18,823.16, and R$ 871.03, respectively. The medication was a major factor in the cost of treatment. Our estimates are comparable to the findings from other studies, but lower than corresponding findings from the international literature.

1498 downloads

12.

AIDS by mother-to-child transmission: survival analysis of cases followed from 1983 to 2002 in different regions of Brazil
Facebook Twitter

Other social networks
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Other networks

Metrics
- SciELO Analytics

Matida, Luiza Harunari

; Ramos Jr., Alberto Novaes

; Moncau, José Eduardo Cajado

; Marcopito, Luiz Francisco

; Marques, Heloisa Helena de Sousa

; Succi, Regina Célia Menezes

; Della Negra, Marinella

; Hearst, Norman

Cadernos de Saúde Pública

Journal Metrics
- Sobre o periódico
- SciELO Analytics

2007, Volume 23 Suppl. 3 Pages S435 - S444

Abstract: Pt En | Text: Pt En | PDF: Pt | PDF: En

2229 downloads Cited 10 times in SciELO

13.

Costs of care provided in a university hospital for children exposed to or infected with the HIV/AIDS
Facebook Twitter

Other social networks
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Other networks

Metrics
- SciELO Analytics

Marques, Heloisa Helena de Sousa

; Couttolenc, Bernard François

; Latorre, Maria do Rosário Dias de Oliveira

; Aquino, Maria Zilda de

; Aveiro, Maria Ignez Garcia

; Pluciennik, Ana Maria Aratangy

Cadernos de Saúde Pública

Journal Metrics
- Sobre o periódico
- SciELO Analytics

2007, Volume 23 Suppl. 3 Pages S402 - S413

Abstract: Pt En | Text: Pt En | PDF: Pt | PDF: En

2175 downloads

14.

Avaliação crítica dos efeitos adversos do tratamento anti-retroviral no feto, recém-nascido e lactente
Facebook Twitter

Other social networks
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Other networks

Metrics
- SciELO Analytics

Marques, Heloisa Helena de Sousa

Revista Brasileira de Ginecologia e Obstetrícia

Journal Metrics
- Sobre o periódico
- SciELO Analytics

jul 2006, Volume 28 N. 7 Pages 424 - 430

Abstract: Pt En | Text: Pt En | PDF: Pt | PDF: En

A introdução da profilaxia da transmissão vertical do HIV com o uso de drogas anti-retrovirais aliadas a outras medidas resultou na redução de crianças infectadas pelo HIV em nosso meio. Esses medicamentos são de uso recente e não há dados conclusivos para definir a sua segurança durante a gravidez. Esse artigo analisa, através de revisão bibliográfica, os possíveis efeitos dessas drogas sobre o feto, o recém-nascido e durante a infância, incluindo o potencial de teratogenicidade, carcinogênese e sua toxicidade. As descrições incluem a identificação de risco aumentado na criança para toxicidade mitocondrial, alterações neurológicas, hematológicas, hepáticas em crianças expostas ao HIV. Baseados nos conhecimentos atuais, considera-se que o benefício na acentuada redução da transmissão vertical do HIV com o uso de drogas anti-retrovirais ultrapassa os riscos eventuais dos efeitos adversos. Entretanto, até que experiência de longo prazo se acumule, é necessário acompanhamento clínico especializado das crianças expostas. Nessa revisão sugere-se uma rotina de acompanhamento clínico-laboratorial ao longo do primeiro ano de vida e depois anualmente até o final da adolescência.

The implementation of prophylactic antiretroviral drugs and others strategies to prevent vertical HIV transmission in Brazil has reduced the number of newly HIV-infected children. Since these drugs are only recently available for treatment, there is no data of conclusive safety during pregnancy and fetus and newborn. This article reviews the possible effects of these drugs in fetus, newborn and childhood, including teratogenesis, carcinogenesis and toxicity. In the literature there are an increasing description of adverse effects such as mithocondrial toxicity, neurological symptoms, blood and liver toxicity in HIV-exposed not infected children. Antiretroviral treatment recommendations are based on principles that known benefit to the pregnat woman should be mantained unless adverse effects outweight the benefit. A long term follow up of HIV- exposed children is proposed to better understanding of these potential toxicity. In this review the author suggests a practical clinical and laboratory routinary evaluation during the first years of life until adolescence for HIV-exposed not infected children.

8796 downloads

15.

A revelação do diagnóstico na perspectiva dos adolescentes vivendo com HIV/AIDS e seus pais e cuidadores
Facebook Twitter

Other social networks
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Other networks

Metrics
- SciELO Analytics

Marques, Heloisa Helena de Sousa

; Silva, Neide Gravato da

; Gutierrez, Pilar Lecussan

; Lacerda, Regina

; Ayres, José Ricardo Carvalho Mesquita

; DellaNegra, Marinella

; França Jr., Ivan

; Galano, Eliane

; Paiva, Vera

; Segurado, Aluisio Augusto Cotrim

; Silva, Mariliza Henrique da

Cadernos de Saúde Pública

Journal Metrics
- Sobre o periódico
- SciELO Analytics

mar 2006, Volume 22 N. 3 Pages 619 - 629

Abstract: Pt En | Text: Pt En | PDF: Pt | PDF: En

O objetivo deste estudo foi identificar aspectos da revelação do diagnóstico da infecção pelo HIV a crianças e adolescentes relevantes para a melhoria do cuidado de sua saúde. Trata-se de estudo qualitativo envolvendo entrevistas em profundidade e grupo focal com adolescentes vivendo com HIV/AIDS e seus pais ou cuidadores, em serviços de referência nas cidades de São Paulo e Santos, Brasil. Os resultados apontam como principais razões para a revelação: má adesão ao tratamento, iminência de início da vida sexual, demanda da criança ou adolescente e abordagem inadequada de profissional. A revelação mostrou-se momento crítico, com repercussões sobre projetos e horizontes de vida dos adolescentes. As mais problemáticas foram narradas por adolescentes infectados por via sexual e por uso de drogas. Apesar do impacto negativo inicial, a revelação repercutiu positivamente sobre os cuidados de saúde, com melhoria do diálogo com cuidadores e serviços. Os adolescentes enfatizaram ainda a necessidade de receber informações claras e honestas. Conclui-se pela necessidade de otimizar o processo de revelação, tratando-o como tarefa de longo prazo, negociada ativamente com a família e conduzida por equipes multidisciplinares.

The purpose of this study was to identify relevant issues in the disclosure of HIV-positive status in children and adolescents, aiming to improve the quality of their healthcare. A qualitative study included adolescents living with HIV/ AIDS and their parents and caregivers at AIDS reference services in São Paulo and Santos, Brazil. In-depth interviews and focus group were used. The main reasons for disclosure were: poor treatment adherence, sexual maturity, adolescent's request, and inadequate procedures by medical staff. Disclosure was a critical moment for adolescents, with a strong impact on their life plans and horizons. Adolescents infected through sexual transmission and drug use reported the most problematic scenes involved in disclosure. Despite its initial negative impact, disclosure resulted in improved healthcare and better dialogue among the adolescents, caregivers, and healthcare providers. The adolescents also requested clear, no-nonsense, honest information. The authors conclude that health services need to actively provide an adequate approach to facilitate disclosure of HIV-positive status to children and adolescents, realizing that it is a long-term process supported by the family and a multidisciplinary team.

6988 downloads Cited 5 times in SciELO

Showing

itens per page

Page of 2 Next

Select one or more results

All Alphabetic

Results

Comparative chart Download CSV

Statistics of

Send result

To*

Use ; (semicolon) to insert more emails.

Send to email

This page

Selected records

All references (max. 300)

Your email

Subject

Comments

Export format:

RIS (for EndNote, ProCite, Reference Manager, RefWorks, Citavi, etc.)

BibTeX

Citation

CSV (for Excel, etc)

Export:

This page

Selected itens

All references (max. 2000)

Sem resultados

No documents were found for your search

Glossary and search help

You can enrich your search in a very simple way. Use the search indexes combined with the connectors (AND or OR) and specify more your search.

For example, if you want to search for articles about
cases of dengue in Brasil in 2015, use:
ti:dengue and publication_year:2015 and aff_country:Brasil

See below the complete list of search indexes that can be used:

Index code	Element
ti	article title
au	author
kw	article keywords
subject	subject (title words, abstract and keywords)
ab	abstract
ta	journal short title (e.g. Cad. Saúde Pública)
journal_title	journal full title (e.g. Cadernos de Saúde Pública)
la	publication language code (e.g. pt - Portuguese, es - Spanish)
type	document type
pid	publication identifier
publication_year	publication year of publication
sponsor	sponsor
aff_country	country code of the author's affiliation
aff_institution	author affiliation institution
volume	article volume
issue	article issue
elocation	elocation
doi	DOI number
issn	journal ISSN
in	SciELO colection code (e.g. scl - Brasil, col - Colômbia)
use_license	article usage license code

SciELO - Scientific Electronic Library Online
Rua Dr. Diogo de Faria, 1087 – 9º andar – Vila Clementino 04037-003 São Paulo/SP - Brasil
Email: scielo@scielo.org

All the contents of this site www.scielo.br, except where otherwise noted, is licensed under a Creative Commons Attribution License.
more »